SA

Sunil Agarwal

Active Director Director DIN 01431202
DIN 01431202 First appointment Sep 2004 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunil Agarwal

Data last updated:

Sunil Agarwal is a Director at Sav Pharmaceuticals Limited (since 2004). The company operates in Pharma.

DIN 01431202
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2004
Oldest Company Age 28 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sav Pharmaceuticals Limited U74899DL1997PLC090639
Director30 Sep 20041997Active

Board colleagues of Sunil Agarwal

Directorship timeline

Open interactive timeline →
Sav Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Sunil Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Agarwal

Sunil Agarwal currently holds 1 directorship: Sav Pharmaceuticals Limited (Director, since 30 Sep 2004).

Sunil Agarwal was first appointed on 30 Sep 2004 as Director at Sav Pharmaceuticals Limited.

The current boards of Sunil Agarwal's companies include Gauri Goel (Sav Pharmaceuticals Limited), Megha Agarwal (Sav Pharmaceuticals Limited), Nalin Agarwal (Sav Pharmaceuticals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available